Image provided by Dr. Farinaz Arbab
The Master's Program in Biomedical Sciences & Biotechnology (BSBT-GEN) is a highly regarded Professional Science Master's Program that offers comprehensive training in the biomedical sciences and key related fields, such as regulations, intellectual property, and entrepreneurship. This program equips students with the skills and knowledge to succeed in the biotechnology industry and can also serve as a stepping-stone for further education, such as in Biomedical Sciences PhD Programs, Medical School, Dental School, or Pharmacy programs.
As of Fall 2019, the BSBT program offers three plans:
Only the BSBT-GEN is recognized by the National Professional Science Master's Association as a Professional Science Master's Program. To earn this recognition, the program must include STEM courses, Plus courses related to science, an advisory board with industry members, and a capstone experiential learning experience, such as an internship.
The BSBT-MIM and BSBT-SBB are more research-intensive and require a traditional thesis for graduation.
Graduation from the BSBT program requires 38 credits and a selected internship (BSBT-GEN) or a traditional thesis (BSBT-MIM and BSBT-SBB), allowing students to tailor their education to their career goals. Students take required and elective courses at either CU Denver or the CU Anschutz Medical Campus.
All three BSBT program plans provide excellent preparation for careers in the biomedical sciences and biotechnology fields and have a successful track record of producing alumni who have secured employment in industry and academia, as well as those who have gone on to pursue further education in Medical School, Dental School, PhD programs, and more.
Tamara Terzian, PhD
Program Director, Biomedical Sciences and Biotechnology Program
Program Administrator, Biomedical Sciences and Biotechnology Program
Weston Blakeslee | Strategic Advisor, PatchRx
Tim Boyd | Director of Development, Partner Therapeutics, Inc.
Jeff Conn | Interim Executive Director, Colorado Federal Executive Board
April Giles | VP, Business Development, Fitzsimons Innovation Community
Karen Lowitz | Senior Regulatory Affairs Manager, Terumo Blood and Cell Technologies
Angie Purvis | Independent Consultant, Medical Device and Diagnostics
Joanne Rupprecht | Manager of Regulatory Affairs, Office of the Vice President of Research, Colorado State University
Mark Spiecker | President, STAQ PHARMA
Lindsey Summers | Sr Talent Acquisition Partner, Day One Bio
Christopher Tompkins | President & CEO, KromaTiD, Inc.
Robert Traver | Attorney, Sheridan Ross PC / Attorneys at Innovation, patent / trademark / copyright
Steve Van Nurden | CEO and President Fitzsimons, Redevelopment Authority
Lora A.Wilson | Director, Oncology Field Medical, Pfizer
The Advisory Committee for the professional master's program in Biomedical Sciences and Biotechnology typically serves in an advisory capacity to the program director. Their responsibilities and roles include:
Program Development: Advisory Committee members may assist in developing and reviewing the program curriculum, course offerings, and academic policies to ensure that they are aligned with the program's goals and mission.
Industry and Community Engagement: Advisory Committee members may serve as liaisons between the program and industry partners or other stakeholders in the community. They may help to identify new opportunities for collaboration or provide guidance on current industry trends.
Student Support: Advisory Committee members may provide guidance and support to students in the program, such as through mentoring or networking opportunities.
Resource Development: Advisory Committee members may assist in identifying and securing resources needed to support the program, such as funding or research partnerships.
Quality Assurance: Advisory Committee members may provide guidance on the program's quality assurance processes, including student assessment and evaluation.
Public Relations: Advisory Committee members may assist in promoting the program and building its reputation in the field.
Overall, the Advisory Committee serves as a valuable resource for the BSBT program, providing guidance and expertise to ensure its success. To apply for our BSBT Advisory Committee, please contact email@example.com
Laurence Freeman | Co-Founder and CEO Oakbay LLC, Healthcare Intellectual Property Commercialization and Management| Professor (Adjunct) Healthcare Innovation and Entrepreneurship, Jake Jabs Center of Entrepreneurship University of Colorado
Denver Business School
Freeman LinkedIn Profile
Arlen Myers, MD MBA | Emeritus Professor, University of Colorado School of Medicine; President and CEO, Society of Physician Entrepreneurs
Myers LinkedIn Profile
Rose Nash, PhD | Biotech Startup Professional; Chief Operating Officer, Burst Diagnostics; Founder, CEO LimitlessBio; co-founder, CEO BorderlessBio; Startup professional ushering molecular assays from concept to market for broad range of applications including infectious disease surveillance and diagnostics.
Enrique Torchia, PhD | Director of Health Outcome and Research & member of the Medical and Scientific Advisory Committee, The Sun Bus; Independent Research Contractor, MycoTechnology, Inc.; Assistant Professor, Department of
Dermatology & Gates Institute, School of Medicine, University of Colorado Anschutz Medical Campus
Torchia LinkedIn Profile
Lori Walker, PhD | Associate Professor, Department of Medicine, Division of Cardiology, School of Medicine, University of Colorado Anschutz Medical Campus
Walker LinkedIn Profile